Purchases and Sales Made in Q2 2021 in Reata Pharmaceuticals Inc (RETA)
This table provides information about the institutional ownership of Reata Pharmaceuticals Inc (RETA) during Q2 2021. The information is specifically focused on institutions that hold shares of REATA PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2021
Q2 2021
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-120K- 28.57% |
$9.39M - $18.2M
|
300K
$0
|
|
|
Jul 20, 2021
Q2 2021
|
Candriam S.C.A.
|
SELL
|
- |
-152KClosed |
$11.9M - $23M
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-159K- 66.63% |
$12.4M - $24M
|
79.6K
$0
|
|
|
Aug 10, 2021
Q2 2021
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-194KClosed |
$15.2M - $29.3M
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-232K- 57.96% |
$18.1M - $35.1M
|
168K
$0
|